These results also suggest the possibility of modulating host cell Rab18 or TRAPPC9 expression by miR-1914-3p or other small molecules to block the acquisition of FAs from LBs which may be exploited for developing potential therapeutic application against leishmaniasis. This evidence concerns the gene RAB18 and leishmaniasis.